Four HealthTech Merger Theories: Synergy Theory, Agency Theory, Market Power Theory, Strategic Similarity Theory

Lloyd Price
Jun 26
5 min read

Mergers and acquisitions (M&A) in the HealthTech sector are driven by a complex interplay of strategic, financial, and organizational factors. Understanding the underlying theories helps to explain why these deals occur and what their potential outcomes might be. Here are four key theories that are particularly relevant to HealthTech mergers:

1. Synergy Theory

Core Idea: Synergy theory posits that the combined value of two merging companies is greater than the sum of their individual parts (VA+B>VA+VB). This "extra" value is created through efficiencies, expanded capabilities, and shared resources that wouldn't be possible if the companies operated independently.

In HealthTech:

Cost Synergies: This is often the most straightforward. Mergers can eliminate redundant operations (e.g., duplicate administrative departments, sales teams, or IT infrastructure). For example, two HealthTech companies merging might consolidate their back-office functions, leading to significant cost savings.
Revenue Synergies: The combined entity can generate more revenue than the two separate companies. This could be achieved through cross-selling products or services to an expanded customer base, entering new geographical markets, or offering a more comprehensive solution that attracts more clients. For instance, a company specialising in telehealth platforms merging with a company offering remote patient monitoring devices could create a more attractive, integrated offering.
Strategic & Clinical Synergies: This relates to improved patient care, enhanced technological capabilities, and increased market competitiveness. A merger might bring together complementary technologies (e.g., AI diagnostics with electronic health records) to create innovative solutions, or combine clinical expertise to improve patient outcomes.

2. Agency Theory

Core Idea: Agency theory examines the relationship between a principal (e.g., shareholders) and an agent (e.g., company management). It suggests that conflicts of interest can arise when the agent's motivations (e.g., personal gain, empire building) do not perfectly align with the principal's goal of maximising shareholder wealth.

In HealthTech:

Managerial Self-Interest: In HealthTech mergers, managers might pursue acquisitions that increase the size and prestige of their company, even if the financial benefits to shareholders are questionable. This could involve acquiring a company to gain market share, access new technologies, or expand their professional influence, potentially leading to overpayment for the target company.
Risk Aversion/Tolerance: Principals and agents may have different risk appetites. Shareholders might prefer stable, long-term growth, while management might be more inclined to pursue high-risk, high-reward acquisitions that could boost their compensation or reputation in the short term.
Information Asymmetry: Managers often have more information about the target company and the integration process than shareholders. This information asymmetry can allow managers to make decisions that benefit themselves, even if they are not optimal for the shareholders. Incentives like stock options are sometimes used to align managerial interests with those of shareholders.

3. Market Power Theory

Core Idea: Market power theory suggests that mergers are driven by the desire to increase market concentration, reduce competition, and gain greater control over pricing and supply. This can lead to higher profits for the merged entity, but potentially at the expense of consumers (e.g., higher prices, fewer choices).

In HealthTech:

Reduced Competition: A merger between two competing HealthTech companies can reduce the number of players in a specific segment (e.g., remote monitoring, healthcare AI). This allows the combined entity to have more influence over pricing and product offerings, potentially leading to less innovation or higher costs for healthcare providers and patients.
Increased Bargaining Power: A larger, merged HealthTech company can have greater bargaining power with suppliers, customers (hospitals, clinics, insurers), and even regulatory bodies. This can lead to more favourable terms for the merged entity, potentially impacting the broader healthcare ecosystem.
Consolidation in Specialized Niches: In HealthTech, there are many highly specialized niches. Mergers in these areas can quickly lead to significant market power for the dominant players, as the barriers to entry for new competitors might be high due to regulatory hurdles, data requirements, or specialized expertise. Regulators often scrutinise such mergers to prevent anti-competitive practices.

4. Strategic Similarity Theory

Core Idea: Strategic similarity theory posits that mergers are more likely to occur, and more likely to be successful, when the acquiring and target companies have similar competitive strategies, resource allocation approaches, and organizational cultures. This alignment reduces integration challenges and facilitates the realisation of synergies.

In HealthTech:

Aligned Business Models: If both companies focus on similar types of customers (e.g., large hospital systems, individual practitioners), delivery models (e.g., SaaS, on-premise), or technological approaches (e.g., cloud-native, legacy systems), integration can be smoother.
Shared Vision and Culture: A high degree of strategic similarity often implies a shared vision for the future of healthcare technology and compatible organisational cultures. This can significantly reduce post-merger integration challenges related to employee morale, operational processes, and decision-making.
Complementary Strengths within a Similar Strategy: Even with similar strategies, companies can have complementary strengths. For example, two HealthTech companies both focused on improving patient engagement might merge, with one bringing a strong mobile app platform and the other excelling in data analytics for patient behaviour. Their strategic goal is similar, but their specific capabilities complement each other.
Faster Integration and Value Realisation: When strategies are similar, the combined entity can more quickly align on common goals, integrate systems, and leverage shared resources, leading to faster realisation of anticipated synergies and better overall deal performance.

These four theories provide a comprehensive framework for understanding the diverse motivations and potential outcomes of mergers and acquisitions in the rapidly evolving HealthTech landscape.

Nelson Advisors > Healthcare Technology M&A

Nelson Advisors specialise in mergers, acquisitions & partnerships for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies based in the UK, Europe and North America. www.nelsonadvisors.co.uk

Nelson Advisors regularly publish Healthcare Technology thought leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital

We share our views on the latest Healthcare Technology mergers, acquisitions & partnerships with insights, analysis and predictions in our LinkedIn Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb

Founders for Founders > We pride ourselves on our DNA as ‘HealthTech entrepreneurs advising HealthTech entrepreneurs.’ Nelson Advisors partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk

#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #BuySide #SellSide